Saturday, October 3, 2026

Ripple On Bearish Momentum: 7.6% Down In The Last 24 Hours

ViaNews Editorial Team

December 16, 2020

Ripple On Bearish Momentum: 7.6% Down In The Last 24 Hours

Ripple is currently on bearish momentum. At 05:03 EST on Wed 16 Dec, Ripple is at $0.45 and down by 7.6% in the last 24 hours.

Ripple Range

Over the last six hours, Ripple's higher value was $0.46 and the lower value was $0.45.

Over the last twelve hours, Ripple's higher value was $0.47 and the lower value was $0.44.

In relation to Ripple's daily highs and lows, it's 2.614% up from its trailing 24-hour low of $0.44 and 7.857% down from its trailing 24-hour high of $0.49.

In relation to the Ripple's yearly highs and lows, it's 292.268% up from its 52-week low and 41.211% down from its 52-week high.

News about Bitcoin

What is Bitcoin worth? little consensus in fragmented market. According to The Wall Street Journal on Sun Dec 13, "Bitcoin enthusiasts agree the digital currency hit a record recently. ", "Bitcoin and hundreds of other cryptocurrencies trade on independent exchanges around the world. "

JPMorgan says massmutual’s Bitcoin foray signals widening demand. According to Bloomberg Quint on Mon Dec 14, "The $100 million purchase suggests adoption of Bitcoin is spreading from family offices and wealthy investors to insurance firms and pension funds, strategists including Nikolaos Panigirtzoglou said in a note Friday. ", "A recent investment in Bitcoin by Massachusetts Mutual Life Insurance Co. highlights the potential for additional institutional demand for the cryptocurrency in coming years, according to JPMorgan Chase & Co."

Fund managers see Bitcoin trade crowded as institutions jump in. According to Bloomberg Quint on Tue Dec 15, "About 15% of fund managers, with $534 billion under management, surveyed by Bank of America Corp. said Bitcoin is the third-most crowded trade behind being long technology shares and shorting the U.S. dollar. ", "Bitcoin's dizzying rally in 2020 has captivated the professional investing class."

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Pharma Pipeline Catalysts and M&A Heat Up as AI-Designed Drugs Enter the Clinic
Late-September 2026 brought a dense run of clinical readouts: Novo Nordisk's CagriSema data at EASD, Lilly's ADtouch results for EBGLYSS, and Merck's tulisokibart Phase 2b result. Lilly's $2.9B Merida Biosciences acquisition and the 2026-11-14 FDA PDUFA date for ivonescimab sit alongside these as the main deal and regulatory events. AI-designed drugs such as rentosertib, and speculative AI-linked trial ventures such as QAIAx, are moving from hype toward clinical validation. Broader AI-sector regulatory and legal friction (Tesla Cybercab probe, xAI Minnesota ruling, OpenAI lawsuits) shows rising scrutiny that could spill into AI-driven healthcare.
Our read on the data ›
Signals we're tracking
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patterns we're watching ›
Where sources disagree
Apple Inc.
The observation date (2025-12-27) precedes Q1 2026, making it logically impossible to have actual Q1 2026 cash data at that point. Q1 2026 would not end until March 31, 2026. Additionally, the magnitude of the difference ($45.3B vs $132.42) is implausibly large even as a normal quarterly change for Apple. While different fiscal periods can show different values, the timing relationship here suggests a data integrity issue rather than legitimate period-over-period variation.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,985
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,985 facts checked against source5,329 source documents archived
Query this data → isubstrate.com